These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 15017564)

  • 1. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study.
    Billmire D; Vinocur C; Rescorla F; Cushing B; London W; Schlatter M; Davis M; Giller R; Lauer S; Olson T;
    J Pediatr Surg; 2004 Mar; 39(3):424-9; discussion 424-9. PubMed ID: 15017564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant retroperitoneal and abdominal germ cell tumors: an intergroup study.
    Billmire D; Vinocur C; Rescorla F; Colombani P; Cushing B; Hawkins E; Davis M; London WB; Lauer S; Giller R;
    J Pediatr Surg; 2003 Mar; 38(3):315-8; discussion 315-8. PubMed ID: 12632341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.
    Rogers PC; Olson TA; Cullen JW; Billmire DF; Marina N; Rescorla F; Davis MM; London WB; Lauer SJ; Giller RH; Cushing B; ;
    J Clin Oncol; 2004 Sep; 22(17):3563-9. PubMed ID: 15337806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a pediatric intergroup trial (POG 9049/CCG 8882).
    Rescorla F; Billmire D; Stolar C; Vinocur C; Colombani P; Cullen J; Giller R; Cushing B; Lauer S; Davis M; Hawkins E; Shuster J; Krailo M
    J Pediatr Surg; 2001 Jan; 36(1):12-7. PubMed ID: 11150431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.
    Tangir J; Zelterman D; Ma W; Schwartz PE
    Obstet Gynecol; 2003 Feb; 101(2):251-7. PubMed ID: 12576247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative surgical management of malignant ovarian germ cell tumors: the experience of the Gynecologic Oncology Unit at Ain Shams University.
    El-Lamie IK; Shehata NA; Abou-Loz SK; El-Lamie KI
    Eur J Gynaecol Oncol; 2000; 21(6):605-9. PubMed ID: 11214621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
    Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
    World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.
    Culine S; Kattan J; Lhomme C; Duvillard P; Michel G; Castaigne D; Leclere J; Pico J; Droz JP
    Gynecol Oncol; 1994 Jul; 54(1):47-53. PubMed ID: 7517380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant mediastinal germ cell tumors: an intergroup study.
    Billmire D; Vinocur C; Rescorla F; Colombani P; Cushing B; Hawkins E; London WB; Giller R; Lauer S
    J Pediatr Surg; 2001 Jan; 36(1):18-24. PubMed ID: 11150432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of neoadjuvant chemotherapy and surgery in children with malignant germ cell tumors of the genital region: a pediatric intergroup trial.
    Rescorla F; Billmire D; Vinocur C; Colombani P; London W; Giller R; Cushing B; Lauer S; Cullen J; Davis M; Hawkins E
    J Pediatr Surg; 2003 Jun; 38(6):910-2. PubMed ID: 12778391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity.
    Mann JR; Raafat F; Robinson K; Imeson J; Gornall P; Sokal M; Gray E; McKeever P; Hale J; Bailey S; Oakhill A
    J Clin Oncol; 2000 Nov; 18(22):3809-18. PubMed ID: 11078494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant germ cell tumors in childhood.
    Nair R; Pai SK; Saikia TK; Nair CN; Kurkure PA; Gopal R; Sampat MS; Advani SH
    J Surg Oncol; 1994 Jul; 56(3):186-90. PubMed ID: 7518019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group.
    Shaikh F; Cullen JW; Olson TA; Pashankar F; Malogolowkin MH; Amatruda JF; Villaluna D; Krailo M; Billmire DF; Rescorla FJ; Egler RA; Dicken BJ; Ross JH; Schlatter M; Rodriguez-Galindo C; Frazier AL
    J Clin Oncol; 2017 Apr; 35(11):1203-1210. PubMed ID: 28240974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
    Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
    Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.
    Billmire DF; Cullen JW; Rescorla FJ; Davis M; Schlatter MG; Olson TA; Malogolowkin MH; Pashankar F; Villaluna D; Krailo M; Egler RA; Rodriguez-Galindo C; Frazier AL
    J Clin Oncol; 2014 Feb; 32(5):465-70. PubMed ID: 24395845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
    Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
    Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.
    Motzer RJ; Sheinfeld J; Mazumdar M; Bajorin DF; Bosl GJ; Herr H; Lyn P; Vlamis V
    J Clin Oncol; 1995 Nov; 13(11):2700-4. PubMed ID: 7595727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to high-dose cisplatin and etoposide in advanced germ cell tumors in children: results of the Brazilian Germ Cell Tumor Study.
    Lopes LF; de Camargo B; Dondonis M; de Araujo RA; Morinaka E
    Med Pediatr Oncol; 1995 Nov; 25(5):396-9. PubMed ID: 7674997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical treatment of ovarian malignant germ cell tumors in the adult].
    Culine S; Lhommé C; Droz JP
    Bull Cancer; 1997 Sep; 84(9):919-21. PubMed ID: 9435816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.